FF
ABBV icon

Farrell Financial’s AbbVie ABBV Stock Holding History

Farrell Financial’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$361K Sell
1,435
-12
-0.8% -$2.58K 0.2% 61
2026
Q1 		$315K Buy
+1,447
New +$321K 0.19% 64

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Farrell Financial's ABBV Position: Q2 2026 in Review

Farrell Financial reduced its AbbVie (ABBV) stake by 0.83% in Q2 2026, selling an estimated $2.58K and leaving 1,435 shares worth $361K. The position accounts for 0.2% of the portfolio, ranked #61.

Farrell Financial first reported a position in ABBV in Q1 2026 and has held it in 2 quarters since. 803 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Farrell Financial held 1,435 shares of AbbVie worth $361K as of Q2 2026.
  • Farrell Financial sold 12 AbbVie shares in Q2 2026, an estimated $2.58K.
  • AbbVie made up 0.2% of Farrell Financial's portfolio in Q2 2026, its #61 holding.
  • Farrell Financial first reported a position in AbbVie in Q1 2026 and has held it in 2 quarters since.
  • 803 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Farrell Financial's 13F filing for Q2 2026, filed 10 Jul 2026.